UK markets closed

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9206+0.0006 (+0.07%)
As of 02:29PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
54,518
58,246
57,263
42,224
22,629
Selling general and administrative
16,483
17,009
21,120
21,971
11,098
Total operating expenses
71,001
75,255
78,383
64,195
33,727
Operating income or loss
-71,001
-75,255
-78,383
-64,195
-33,727
Total other income/expenses net
6,992
6,081
7,318
3,133
531
Income before tax
-64,009
-69,174
-71,065
-61,062
-33,196
Income tax expense
424
491
111
37
3
Income from continuing operations
-64,433
-69,665
-71,176
-61,099
-33,199
Net income
-64,433
-69,665
-71,176
-61,099
-33,199
Net income available to common shareholders
-64,433
-69,665
-71,176
-61,099
-33,199
Basic EPS
-1.90
-1.74
-1.82
-2.13
-0.82
Diluted EPS
-1.90
-1.74
-1.82
-2.13
-0.82
Basic average shares
39,737
39,973
39,140
28,655
40,622
Diluted average shares
39,737
39,973
39,140
28,655
40,622